TOMATIS, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 3.778
EU - Europa 831
AS - Asia 562
AF - Africa 2
SA - Sud America 2
OC - Oceania 1
Totale 5.176
Nazione #
US - Stati Uniti d'America 3.776
CN - Cina 350
UA - Ucraina 270
TR - Turchia 200
DE - Germania 140
GB - Regno Unito 136
SE - Svezia 82
IT - Italia 64
FI - Finlandia 59
BE - Belgio 48
FR - Francia 21
IN - India 8
NL - Olanda 5
IR - Iran 3
DK - Danimarca 2
ZA - Sudafrica 2
AU - Australia 1
CA - Canada 1
CL - Cile 1
CZ - Repubblica Ceca 1
ES - Italia 1
KG - Kirghizistan 1
MX - Messico 1
RO - Romania 1
RU - Federazione Russa 1
VE - Venezuela 1
Totale 5.176
Città #
Fairfield 531
Woodbridge 484
Houston 363
Jacksonville 291
Ann Arbor 285
Ashburn 249
Chandler 242
Seattle 211
Wilmington 182
Cambridge 155
Izmir 83
Nanjing 80
Beijing 77
San Diego 60
Princeton 58
Brussels 48
Dearborn 44
Milan 35
Boardman 33
Shenyang 30
Nanchang 29
Hebei 19
New York 19
San Mateo 19
Auburn Hills 18
Changsha 15
Bremen 14
Shanghai 14
Tianjin 14
Addison 13
Jiaxing 12
Zhengzhou 10
Jinan 9
Kunming 9
Falls Church 8
Mountain View 8
Los Angeles 7
Ningbo 7
Philadelphia 7
Augusta 6
Ferrara 6
Hefei 6
London 6
Norwalk 6
Des Moines 5
Guangzhou 5
Hounslow 5
Redwood City 5
Washington 5
Verona 4
Bologna 3
Düsseldorf 3
Helsinki 3
Indiana 3
Mumbai 3
Prescot 3
Taizhou 3
Acton 2
Ardabil 2
Haikou 2
Hanover Park 2
Lanzhou 2
Leawood 2
Tappahannock 2
Yellow Springs 2
Bishkek 1
Bolton 1
Brno 1
Cape Town 1
Changchun 1
Chicago 1
Chiswick 1
Copenhagen 1
Delhi 1
Distrito Federal 1
Ercolano 1
Garza García 1
Hangzhou 1
Hanover 1
Madrid 1
Melbourne 1
Monmouth Junction 1
Orange 1
Portland 1
Pune 1
Rhodes 1
San Francisco 1
Southwark 1
Toronto 1
Walnut 1
Zhoushan 1
Totale 3.914
Nome #
A CYCLIC PEPTIDE T ANALOGUE WITH HIGH CHEMOTACTIC ACTIVITY 149
C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors 132
Vinyl ester-based cyclic peptide proteasome inhibitors 129
Opioid agonists and antagonists. Peptides containing N-terminal allyl groups and/or a thiomethylene linkage in place of a peptide bond 120
Dermorphin, a new opioid peptide, stimulates thyrotropin secretion in normal subjects 120
Synthesis and biological evaluation of new vinyl ester pseudotripeptide proteasome inhibitors 119
Arecoline tripeptide inhibitors of proteasome 119
Stimulatory effect of dermorphin, a new synthetic potent opiate-like peptide, on human growth hormone secretion 117
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 115
Peptide analogues of a subdominant epitope expressed in EBV-associated tumors: synthesis and immunological activity 112
Cholinergic mediation in dermorphin-induced growth hormone secretion in man 112
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 111
Responses of plasma renin activity, aldosterone, adrenocorticotropin, and cortisol to dermorphin, a new synthetic potent opiate-like peptide, in man 111
P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors 110
Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides 110
Dermorphin inhibits spinal nociceptive flexion reflex in humans 106
2-Aminoamides and Pseudopeptides Carrying an Amino Group Common to two Residues 106
Peptidyl vinyl ester derivatives: New class of selective inhibitors of proteasome trypsin-like activity 105
Prolactin-Releasing Activity of Dermorphin, a New Synthetic Potent Opiate-Like Peptide, in Normal Human Subjects 105
α,β-Unsaturated N-Acylpyrrole Peptidyl Derivatives: New Proteasome Inhibitors 104
Cytotoxic T lymphocyte epitope analogues containing cis- or trans-4-aminocyclohexanecarboxylic acid residues 102
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides 102
Prolactin and growth hormone responses to dermorphin in patients with prolactin-secreting pituitary adenoma 102
Opioid deltorphin C analogues containing cis- or trans-2- or 3- or 4-aminocyclohexanecarboxylic acid residues 100
Design of dimeric peptides obtained from a subdominant Epstein-Barr virus LMP2-derived epitope 98
null 96
Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes 96
Somatostatin Inhibits the Dermorphin-Stimulated Thyrotropin Release in Man 95
High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes 92
A Single Specific Amino Acid Residue in Peptide Antigens Is Sufficient to Activate Memory CTL: Potential Role of Cross-Reactive Peptides in Memory T Cell Maintenance 91
null 90
null 89
null 88
Synthesis and activity of dermorphine growth hormone releasing factor hybrid peptides 87
N-Terminal-prolonged vinyl ester-based peptides as selective proteasome b1 subunit inhibitors 86
Pharmacological studies of a series of dermorphin related tetrapeptides 85
Synthesis and activity profiles of new dermorphin-(1-4) peptide analogues 84
Dermorphin decreases plasma LH levels in human: Evidence for a modulatory role of gonadal steroids 84
Polymorphonuclear neutrophils pulsed with synthetic peptides efficiently activate memory cytotoxic T lymphocytes. 81
Synthesis and structure activity relationships of delthorphine analogues 80
New cyclic peptide proteasome inhibitors 78
Opioid peptides. Partially modified retro-inverso dermorphin analogues 78
Opioid peptides. Biological study of (D-Meto2) dermorphin analogues in relation to the plurality of opioid receptors 75
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 70
Synthesis and activity of pseudotripeptide inhibitors of HIV-1 protease containing D(-)-O-(benzyl)tartaric acid. 68
No acute effect of naloxone and dermorphin on calcitonin secretion in man 67
Glutamine vinyl ester proteasome inhibitors selective for trypsin-like (beta2) subunit 64
null 62
Proteasome inhibitors: synthesis and activity of arecoline oxide tripeptide derivatives 62
Structure activity relationship for dermophin related tetrapeptides 62
Chromatographic parameters of lipophilicity of a series of dermorphin related oligopeptides. 58
Dermorphin reduces the metyrapone-evoked release of adrenocorticotropin, beta-endorphin, and beta-lipotropin in man 58
Opioid peptides. Analgesic activity of potent dermorphin tetrapeptides. VI. 58
Peptide-based molecules for the production of positive charged liposomes and micelles 56
Pharmacological activity and lipophilic character of dermorphin oligopeptides 49
Opioid peptides. Synthesis and biological properties of dermorphin, related hexapeptides 49
Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals 28
Selective amino acid substitutions of a subdominant Epstein-Barr virus LMP2-derived epitope increase HLA/peptide complex stability and immunogenicity: implications for immunotherapy of Epstein-Barr virus-associated malignancies 16
HIV protease inhibitors: synthesis and activity of N-aryl-N '-hydroxyalkyl hydrazide pseudopeptides 15
Synthesis and Pharmacological Activity of a Superagonist of the ORL-1 Receptor 1
Totale 5.214
Categoria #
all - tutte 16.309
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 191
Totale 16.500


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019640 0 0 0 0 0 0 0 6 58 133 179 264
2019/20201.242 210 39 41 170 85 148 138 137 99 108 44 23
2020/2021703 63 74 20 101 20 75 41 76 15 78 109 31
2021/2022741 27 45 58 58 64 31 29 37 24 42 63 263
2022/2023584 63 33 18 70 88 81 43 52 70 10 32 24
2023/2024232 29 44 26 14 40 46 12 21 0 0 0 0
Totale 5.214